154 related articles for article (PubMed ID: 18333019)
1. Parathyroid hormone-related peptide in pancreatic neuroendocrine tumours associated with hypercalcaemia.
Papazachariou IM; Virlos IT; Williamson RC
HPB (Oxford); 2001; 3(3):221-5. PubMed ID: 18333019
[TBL] [Abstract][Full Text] [Related]
2. Case report of multimodality treatment for metastatic parathyroid hormone-related peptide-secreting pancreatic neuroendocrine tumour.
Rossi RE; Naik K; Navalkissoor S; Imber C; O'Beirne J; Toumpanakis C; Caplin ME
Tumori; 2014; 100(4):153e-6e. PubMed ID: 25296608
[TBL] [Abstract][Full Text] [Related]
3. Malignant hypercalcaemia related to parathyroid hormone-related peptide (PTHrP) secretion from a metastatic pancreatic neuroendocrine tumour (NET).
Symington M; Davies L; Kaltsas G; Weickert MO
BMJ Case Rep; 2017 Mar; 2017():. PubMed ID: 28331027
[TBL] [Abstract][Full Text] [Related]
4. Somatostatin receptor expression in a parathyroid hormone-related peptide-secreting pancreatic neuroendocrine tumour causing severe hypercalcaemia.
Müssig K; Petersenn S; Wehrmann M; Horger M; Vierling P; Häring HU; Gallwitz B
Eur J Gastroenterol Hepatol; 2007 Aug; 19(8):719-23. PubMed ID: 17625444
[TBL] [Abstract][Full Text] [Related]
5. Intractable hypercalcaemia due to parathyroid hormone-related peptide secretion by a carcinoid tumour.
Mantzoros CS; Suva LJ; Moses AC; Spark R
Clin Endocrinol (Oxf); 1997 Mar; 46(3):373-5. PubMed ID: 9156050
[TBL] [Abstract][Full Text] [Related]
6. Rare case of pancreatic neuroendocrine tumour presenting as paraneoplastic hypercalcaemia.
Ferrel B; Franko J; Tee MC
BMJ Case Rep; 2021 Apr; 14(4):. PubMed ID: 33858893
[TBL] [Abstract][Full Text] [Related]
7. Parathyroid hormone-related peptide-secreting pancreatic neuroendocrine tumours: case series and literature review.
Srirajaskanthan R; McStay M; Toumpanakis C; Meyer T; Caplin ME
Neuroendocrinology; 2009; 89(1):48-55. PubMed ID: 18679021
[TBL] [Abstract][Full Text] [Related]
8. Functional evidence for two types of parathyroid adenoma.
D'Amour P; Weisnagel J; Brossard JH; Ste-Marie LG; Rousseau L; Lepage R
Clin Endocrinol (Oxf); 1998 May; 48(5):593-601. PubMed ID: 9666871
[TBL] [Abstract][Full Text] [Related]
9. Hypercalcaemia caused by a carcinoid tumour.
Brzozowska MM; Wolmarans L; Conaglen JV
Intern Med J; 2009 Jun; 39(6):415-8. PubMed ID: 19580622
[TBL] [Abstract][Full Text] [Related]
10. Recurrent hypercalcemia due to ectopic production of parathyroid hormone-related protein and intact parathyroid hormone in a single patient with multiple malignancies.
Eid W; Wheeler TM; Sharma MD
Endocr Pract; 2004; 10(2):125-8. PubMed ID: 15256329
[TBL] [Abstract][Full Text] [Related]
11. Functional pancreatic neuroendocrine tumour causing Cushing's syndrome: the effect of chemotherapy on clinical symptoms.
do Amor Divino PH; Marchetti KR; Almeida MQ; Riechelmann RP
Ecancermedicalscience; 2017; 11():773. PubMed ID: 29104610
[TBL] [Abstract][Full Text] [Related]
12. Overproduction of an amino-terminal form of PTH distinct from human PTH(1-84) in a case of severe primary hyperparathyroidism: influence of medical treatment and surgery.
Räkel A; Brossard JH; Patenaude JV; Albert C; Nassif E; Cantor T; Rousseau L; D'Amour P
Clin Endocrinol (Oxf); 2005 Jun; 62(6):721-7. PubMed ID: 15943835
[TBL] [Abstract][Full Text] [Related]
13. Hypercalcaemia in melanoma patients associated with increased levels of parathyroid hormone-related protein.
Kageshita T; Matsui T; Hirai S; Fukuda Y; Ono T
Melanoma Res; 1999 Feb; 9(1):69-73. PubMed ID: 10338336
[TBL] [Abstract][Full Text] [Related]
14. Primary hyperparathyroidism or hypercalcaemia of malignancy?
Birkeland KI; Gallefoss F; Olsson S; Haug E
Scand J Clin Lab Invest; 1992 Jun; 52(4):347-9. PubMed ID: 1439519
[TBL] [Abstract][Full Text] [Related]
15. Parathyroid hormone related protein and hypercalcaemia in breast cancer.
Bundred NJ; Ratcliffe WA; Walker RA; Coley S; Morrison JM; Ratcliffe JG
BMJ; 1991 Dec; 303(6816):1506-9. PubMed ID: 1782489
[TBL] [Abstract][Full Text] [Related]
16. Parathyroid carcinoma with pancreatitis causing hypercalcaemic emergency treated with extracorporeal membrane oxygenation-assisted parathyroid resection.
Toyoda M; Suganuma N; Takahashi A; Masuda T; Goda M; Yoshida T; Yukawa N; Yamanaka S; Rino Y; Masuda M
Endocrinol Diabetes Metab Case Rep; 2023 Jan; 2023(1):. PubMed ID: 36606579
[TBL] [Abstract][Full Text] [Related]
17. Parathyroid hormone-related peptide and hypercalcaemia in a dog with functional keratinizing ameloblastoma.
Dhaliwal RS; Tang KN
Vet Comp Oncol; 2005 Jun; 3(2):98-100. PubMed ID: 19379218
[TBL] [Abstract][Full Text] [Related]
18. Parathyroid hormone-related protein (PTHrP) gene expression in solid tumours associated with normocalcaemia and hypercalcaemia.
Dunne FP; Lee S; Ratcliffe WA; Hutchesson AC; Bundred NJ; Heath DA
J Pathol; 1993 Nov; 171(3):215-21. PubMed ID: 8277370
[TBL] [Abstract][Full Text] [Related]
19. Role of assays for parathyroid-hormone-related protein in investigation of hypercalcaemia.
Ratcliffe WA; Hutchesson AC; Bundred NJ; Ratcliffe JG
Lancet; 1992 Jan; 339(8786):164-7. PubMed ID: 1346019
[TBL] [Abstract][Full Text] [Related]
20. Effect of treatment with depot somatostatin analogue octreotide on primary hyperparathyroidism (PHP) in multiple endocrine neoplasia type 1 (MEN1) patients.
Faggiano A; Tavares LB; Tauchmanova L; Milone F; Mansueto G; Ramundo V; De Caro ML; Lombardi G; De Rosa G; Colao A
Clin Endocrinol (Oxf); 2008 Nov; 69(5):756-62. PubMed ID: 18485119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
